Shamburg News · 8-K filed Nov 12, 2026, 4:00 PM EST

Kodiak Sciences Reports Third Quarter 2026 Financial Results and Business Highlights

KOD · Kodiak Sciences Inc.

  • Earnings
  • Materiality: high

Kodiak Sciences reported a third quarter 2026 net loss of $66.2 million, or $1.05 per share on a basic and diluted basis, compared with a net loss of $61.5 million, or $1.16 per share, for the third quarter of 2025. The company ended the quarter with $88.7 million of cash and cash equivalents and said it raised aggregate net proceeds of $69 million from common stock sales under its at-the-market facility after September 30, 2026. The release also reported that the Phase 3 DAYBREAK study met its primary endpoint for Zenkuda and tabirafusp-ted in September 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001193125-26-458248.

Written from the filing by Shamburg Markets. Figures are as reported by the company.